Vesnarinone restores contractility and calcium handling in early endotoxemia.
Vesnarinone restores contractility and calcium handling in early endotoxemia.
复制标题
Vesnarinone 可恢复早期内毒素血症的收缩性和钙处理能力。
DOI:
10.1161/01.cir.102.suppl_3.iii-365
复制
发表时间:
2000
期刊:
影响因子:
37.8
通讯作者:
McGowanJr,FX
中科院分区:
文献类型:
--
作者:
Takeuchi,K;delNido,PJ;Poutias,DN;Cowan,DB;Munakata,M;McGowanJr,FX
Background—Endotoxin (lipopolysaccharide, LPS) is a trigger of the systemic inflammatory response. We have previously found that vesnarinone and amrinone, when given before LPS, prevented cytokine production and LPS-related cardiac dysfunction. We tested the hypothesis that vesnarinone would improve intracellular Ca2+handling and calcium-activated contractile force after the onset of endotoxemia.Methods and Results—Adult rabbits received a bolus injection of LPS or vehicle. Vesnarinone (3 mg/kg) was given intravenously 90 minutes later. Two hours after LPS administration, hearts were perfused in the isolated Langendorff mode. Peak left ventricular developed pressure, ±dp/dt, oxygen consumption (MV̇o2), and rate×pressure product were evaluated in conjunction with fluorescent spectroscopic determinations of intracellular calcium concentrations (Cai) and the rate of Caitransient decline during diastole (τCa). Peak left ventricular developed pressure and ±dp/dt were significantly lower in the LPS group. These were completely restored by vesnarinone. There was significantly slower diastolic calcium removal (increased τCa) in LPS hearts that was also corrected by vesnarinone; however, the cytosolic calcium overload characteristic of LPS hearts was only partially improved. Reduced mechanical inefficiency (the ratio of rate-pressure product to MV̇o2) and myofilament sensitivity to Caiwere also significantly improved by vesnarinone.Conclusions—Acute endotoxemia caused contractile protein calcium insensitivity, oxygen wastage, and abnormal calcium cycling. Vesnarinone, given in the rescue mode, normalized LPS-induced myocardial dysfunction and partially restored abnormal calcium cycling. Although the mechanisms responsible for these effects require further clarification, it appears that agents such as vesnarinone may be useful to treat inflammatory-induced myocardial dysfunction.